TFF Pharmaceuticals (NASDAQ:TFFP) Earns Buy Rating from Anal

Jonestrading initiated coverage on shares of TFF Pharmaceuticals (NASDAQ:TFFP – Get Rating) in a research report report published on Wednesday morning, Benzinga reports. The firm issued a buy rating and a $7.00 price objective on the stock. Separately, HC Wainwright restated a buy rating and issued a $22.00 target price on shares of TFF Pharmaceuticals […]

Related Keywords

Australia , United States , Harlanf Weisman , , Pharmaceuticals Trading Down , Pharmaceuticals Daily , Securities Exchange Commission , Sigma Planning Corp , Virtu Financial , Renaissance Technologies , Quantum Private Wealth , Pharmaceuticals Inc , Get Rating , Trading Down , Exchange Commission , Sigma Investments , Private Wealth , Planning Corp , Thin Film Freezing , Tff Pharmaceuticals , Nasdaq Tffp , Tffp , Medical , Initiated Coverage , Jonestrading ,